Two months ago, the US Department of Defense froze operations at nine biodefence laboratories where work is done on dangerous pathogens.

That there were even candidate vaccines and drugs for Ebola was largely down to spending on biodefence rather than concerns about global health, says Balasegaram.

Thanks to a biodefence building boom over the past decade, there are now 13 such labs planned or operating in the United States.